Literature DB >> 23808966

Molecular modeling of p38α mitogen-activated protein kinase inhibitors through 3D-QSAR and molecular dynamics simulations.

Hsin-Wen Chang1, Fu-Sheng Chung, Chia-Ning Yang.   

Abstract

The p38 mitogen-activated protein kinase (MAPK) signaling pathway plays an essential role in inflammation and other physiological processes. Because specific inhibitors of p38α and p38β MAPK block the production of the major inflammatory cytokines and other proteins, p38α and p38β MAPK represent promising targets for the treatment of inflammation. In this work, a series of p38α inhibitors based on the structural scaffold of 4-benzoyl-5-aminopyrazole were analyzed using a combination of molecular modeling techniques. We generated three-dimensional quantitative structure-activity relationship (3D-QSAR) models for both comparative molecular field analysis (CoMFA) and comparative molecular similarity index analysis (CoMSIA) to highlight the structural requirements for p38 MAPK inhibition. Furthermore, we employed molecular dynamics (MD) simulations and the MM/GBSA method to compare the binding modes and binding free energies of a potent and selective compound interacting with p38α, p38β, p38γ, and p38δ MAPK in detail. Contour maps generated via 3D-QSAR analysis identified several key interactions that were also indicated through MD simulations. The binding free energies calculated via the MM/GBSA method were strongly correlated with experimentally observed biological activities and explained the selective inhibition of p38α and p38β, but not p38γ and p38δ detected here. On the basis of the obtained results, we provide insights regarding the development of novel potent p38α MAPK inhibitors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23808966     DOI: 10.1021/ci4000085

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  5 in total

1.  Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization.

Authors:  Yan Guo; Yulong Jin; Bingfeng Wang; Boping Liu
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

2.  Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors.

Authors:  Agnieszka A Kaczor; Katarzyna M Targowska-Duda; Jayendra Z Patel; Tuomo Laitinen; Teija Parkkari; Yahaya Adams; Tapio J Nevalainen; Antti Poso
Journal:  J Mol Model       Date:  2015-09-08       Impact factor: 1.810

3.  Profiling the interaction mechanism of quinoline/quinazoline derivatives as MCHR1 antagonists: an in silico method.

Authors:  Mingwei Wu; Yan Li; Xinmei Fu; Jinghui Wang; Shuwei Zhang; Ling Yang
Journal:  Int J Mol Sci       Date:  2014-09-01       Impact factor: 5.923

4.  Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site.

Authors:  Utid Suriya; Panupong Mahalapbutr; Thanyada Rungrotmongkol
Journal:  Pharmaceutics       Date:  2022-07-13       Impact factor: 6.525

5.  Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulation.

Authors:  Jiansong Fang; Ping Wu; Ranyao Yang; Li Gao; Chao Li; Dongmei Wang; Song Wu; Ai-Lin Liu; Guan-Hua Du
Journal:  Acta Pharm Sin B       Date:  2014-11-22       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.